Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

In memoriam: John P. Quinn, MD.

Perez F, Arias CA, Bush K, Drusano GL, Lolans K, Munoz-Price LS, Nicolau DP, Queenan AM, Rice LB, Segreti J, Shlaes DM, Weinstein RA, Bonomo RA.

Clin Infect Dis. 2014 Mar;58(5):748-50. doi: 10.1093/cid/cit801. Epub 2013 Dec 12. No abstract available.

2.

In memoriam: James J. Rahal Jr, MD.

Segal-Maurer S, Urban C, Rubin DS, Wehbeh W.

Clin Infect Dis. 2011 Dec;53(12):1301-2. doi: 10.1093/cid/cir708. Epub 2011 Nov 3. No abstract available.

3.

Treatment of health-care-associated infections caused by Gram-negative bacteria: a consensus statement.

Chopra I, Schofield C, Everett M, O'Neill A, Miller K, Wilcox M, Frère JM, Dawson M, Czaplewski L, Urleb U, Courvalin P.

Lancet Infect Dis. 2008 Feb;8(2):133-9. doi: 10.1016/S1473-3099(08)70018-5.

PMID:
18222164
4.

Intra-abdominal infections: do we need to change our antibiotic coverage in this era of Gram negative resistance?

Gopalakrishnan R.

J Assoc Physicians India. 2011 May;59:285. No abstract available.

PMID:
21751603
5.

Editorial: Resistance in gram-negative pathogens: a threat to global health.

Hanson ND.

Curr Pharm Des. 2013;19(2):163. No abstract available.

PMID:
22920832
6.

Importance of antibiotic resistance and resistance mechanisms. Foreword.

Bonomo RA, Rossolini GM.

Expert Rev Anti Infect Ther. 2008 Oct;6(5):549-50. doi: 10.1586/14787210.6.5.549. No abstract available.

PMID:
18847392
7.

Up against the wall.

Torres C.

Nat Med. 2010 Jun;16(6):628-31. doi: 10.1038/nm0610-628.

PMID:
20526310
8.

Antimicrobial resistance in gram-negative pathogens: crafting the tools necessary to navigate the long ascent out of the abyss.

Lautenbach E.

J Infect Dis. 2009 Sep 15;200(6):838-40. doi: 10.1086/605409. No abstract available.

9.

Antibiotic resistance. Nosocomial gram-negative infection.

Gransden WR.

J Med Microbiol. 1997 Jun;46(6):436-9. No abstract available.

PMID:
9379467
10.

Optimising outcomes of hospital infections through appropriate empirical antimicrobial therapy. Introduction.

Lode H.

Clin Microbiol Infect. 2008 Apr;14 Suppl 3:1-2. doi: 10.1111/j.1469-0691.2008.01960.x. No abstract available.

11.

Correlation between antibiotic consumption and resistance of Gram-negative bacteria causing healthcare-associated infections at a university hospital in Taiwan from 2000 to 2009.

Lai CC, Wang CY, Chu CC, Tan CK, Lu CL, Lee YC, Huang YT, Lee PI, Hsueh PR.

J Antimicrob Chemother. 2011 Jun;66(6):1374-82. doi: 10.1093/jac/dkr103. Epub 2011 Mar 24.

12.

A paradigm shift in drug development for treatment of rare multidrug-resistant gram-negative pathogens.

Alemayehu D, Quinn J, Cook J, Kunkel M, Knirsch CA.

Clin Infect Dis. 2012 Aug;55(4):562-7. doi: 10.1093/cid/cis503. Epub 2012 May 18.

13.

Emerging resistance in Gram-negative pathogens and implications for clinical practice.

Cantón R, Lumb J.

Future Microbiol. 2011 Jan;6(1):19-22. doi: 10.2217/fmb.10.150.

14.

Correlations between aminoglycoside consumption and aminoglycoside resistance in Gram-negative bacteria at a tertiary-care hospital in South Korea from 2001 to 2011.

Ku NS, Choi JY, Yong D, Kim JM, Lee K.

Int J Antimicrob Agents. 2013 Apr;41(4):394-5. doi: 10.1016/j.ijantimicag.2012.11.009. Epub 2013 Jan 8. No abstract available.

PMID:
23305659
15.

Bacterial resistance, beta-lactam antibiotics and gramnegative bacteria at ICUs.

Reisinger EC, Allerberger F.

Wien Klin Wochenschr. 1999 Jul 30;111(14):537-8. No abstract available.

PMID:
10467639
16.

Extended-spectrum beta-lactamases: a brief clinical update.

Malloy AM, Campos JM.

Pediatr Infect Dis J. 2011 Dec;30(12):1092-3. doi: 10.1097/INF.0b013e31823c0e9d. Review. No abstract available.

PMID:
22105419
17.

[Septicemia with gram-negative bacilli. The possibilities and limits of an etiological therapy].

Grigore L.

Bacteriol Virusol Parazitol Epidemiol. 1996 Jul-Dec;41(3-4):151-60. Review. Romanian. No abstract available.

PMID:
9116405
18.

Antimicrobial resistance in Europe and its potential impact on empirical therapy.

Rossolini GM, Mantengoli E.

Clin Microbiol Infect. 2008 Dec;14 Suppl 6:2-8. doi: 10.1111/j.1469-0691.2008.02126.x. Review.

19.

New EMA guideline for antimicrobial development.

Ambrose PG, Bhavnani SM, Dudley MN, Ellis-Grosse E, Rubino CM, Drusano GL.

Lancet Infect Dis. 2012 Apr;12(4):265-6. doi: 10.1016/S1473-3099(12)70046-4. No abstract available.

PMID:
22459079
20.

Unmet medical need in infectious diseases.

Hersh AL, Newland JG, Beekmann SE, Polgreen PM, Gilbert DN.

Clin Infect Dis. 2012 Jun;54(11):1677-8. doi: 10.1093/cid/cis275. Epub 2012 Apr 2. No abstract available.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk